ICD-10-CM · Multi-region

M85.59

Aneurysmal bone cyst (ABC) involving two or more distinct skeletal sites simultaneously, coded under the M85.5 family of bone density and structure disorders.

Verified May 8, 2026 · 6 sources ↓

Status
Billable
Chapter
13
Related CPT
10
Region
Multi-region
Drawn from CDCAAPCICD10DataClassbrowserUnboundmedicine

Documentation tips

What should appear in the chart to support M85.59.

Source · Editorial brief grounded in 6 cited references ↓

  • Name every affected site explicitly in the assessment — 'aneurysmal bone cyst of the proximal femur and T10 vertebral body' justifies M85.59 far better than 'multiple ABCs.'
  • Reference the imaging modality and key findings (fluid-fluid levels on MRI, expansile lytic lesion with thin cortical shell) for each site to support medical necessity.
  • If pathology was obtained, link the biopsy result to each lesion site in the note — payers may audit multi-site claims without histologic or radiologic confirmation for each location.
  • Document whether lesions are primary ABCs or secondary ABCs arising within a pre-existing lesion (e.g., giant cell tumor) — secondary ABCs may require an additional code for the underlying lesion.
  • Record laterality for each site even though M85.59 itself does not carry a laterality character, because surgical and procedural codes will require it.
  • Note the clinical rationale for staging if procedures will be performed at separate encounters — this supports subsequent-encounter coding and avoids the appearance of duplicate billing.

Related CPT procedures

Procedure codes commonly billed with M85.59. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

Common coding pitfalls

The recurring mistakes coders make with M85.59 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

  • Assigning M85.59 when only one site is documented: if the note names a single location, use the appropriate site-specific M85.5x code instead.
  • Using M85.59 for an aneurysmal cyst of the jaw — the Excludes2 note at M85.5 directs jaw lesions to M27.4, regardless of whether other skeletal sites are also involved.
  • Coding M85.59 when the underlying condition is polyostotic fibrous dysplasia (Q78.1) or another Excludes1-listed disorder — those codes are mutually exclusive with M85.
  • Failing to link each procedural CPT code to the correct lesion site when multiple surgeries are planned — the multi-site diagnosis alone does not automatically justify multiple same-session procedures without distinct operative documentation.
  • Confusing ABC with simple bone cyst (M85.40–M85.49) or fibrous dysplasia (M85.00–M85.09) — histologic or advanced imaging confirmation distinguishes these entities and determines the correct code family.

Clinical context

Source · Editorial summary grounded in 6 cited references ↓

M85.59 applies when an aneurysmal bone cyst — a benign, expansile, blood-filled lesion with characteristic septated cavities — is documented at multiple skeletal sites in the same patient. ABCs most commonly affect the metaphyses of long bones (femur, tibia, humerus) and the posterior elements of the vertebral column, but they can arise in virtually any bone. Use M85.59 only when the operative report, imaging interpretation, or attending note explicitly identifies involvement at more than one site; if only a single site is active, select the site-specific subcategory (e.g., M85.51 shoulder, M85.52 upper arm, M85.56 lower leg).

Important exclusion: do not use M85.59 — or any M85.5 code — when the aneurysmal cyst is located in the jaw. Jaw ABCs map to M27.4 per the Excludes2 note at M85.5. Similarly, M85 as a category is excluded from use when the underlying diagnosis is osteogenesis imperfecta (Q78.0), osteopetrosis (Q78.2), osteopoikilosis (Q78.8), or polyostotic fibrous dysplasia (Q78.1) — those conditions have their own dedicated codes.

In orthopedic practice, M85.59 surfaces in pre-operative documentation for staged resection, curettage, or bone grafting procedures when two or more lesions are being addressed, as well as in post-biopsy management planning. Confirm that radiology (MRI preferred; CT for cortical detail) or pathology has characterized each lesion before assigning the multi-site code — imaging alone showing fluid-fluid levels in multiple bones is strong supporting evidence.

Sibling codes

Other billable codes under M85.5 (laterality / anatomic variants).

Frequently asked questions

Source · Generated from the editorial pipeline, verified against 6 cited references ↓

01What is the minimum documentation required to use M85.59 instead of a single-site M85.5x code?
The treating provider must explicitly document aneurysmal bone cyst at two or more distinct skeletal sites, supported by imaging or pathology for each location. A vague phrase like 'possible additional lesion' is not sufficient — the note should name every site.
02Can M85.59 be used when the jaw is one of the affected sites?
No. The Excludes2 note at M85.5 directs aneurysmal cysts of the jaw to M27.4. If the jaw is involved alongside other skeletal sites, assign M27.4 for the jaw lesion and the appropriate M85.5x code(s) for the other site(s) — M85.59 if two or more non-jaw sites are affected.
03How does M85.59 interact with the Excludes1 conditions listed under M85?
M85 carries Excludes1 notes for osteogenesis imperfecta (Q78.0), osteopetrosis (Q78.2), osteopoikilosis (Q78.8), and polyostotic fibrous dysplasia (Q78.1). Excludes1 means these codes cannot be assigned together with M85.59 — if one of those conditions is the correct diagnosis, use the Q78 code instead.
04Is M85.59 appropriate for a secondary aneurysmal bone cyst arising within a giant cell tumor?
It may be, but the underlying lesion should also be coded. Secondary ABCs develop within pre-existing bone pathology; document and code both the primary lesion (e.g., giant cell tumor) and the ABC component. Query the pathologist's report to confirm the secondary nature before finalizing the code selection.
05Which imaging finding best supports the M85.59 diagnosis in the medical record?
MRI demonstrating fluid-fluid levels within expansile, septated lesions at multiple skeletal sites is the strongest radiologic support. CT can document cortical thinning and expansion. Reference the specific findings and affected bones in the assessment to anchor the multi-site code.
06Does M85.59 require a 7th-character extension?
No. M85.59 is an M-code (musculoskeletal disease chapter), not an injury S-code. The 7th-character A/D/S extension system applies to trauma codes; it is not used with M85.59.
07If staged surgeries are planned for two separate ABC lesion sites, should M85.59 appear on both claims?
Yes, M85.59 can appear on both claims as long as the multi-site diagnosis remains active and documented at each encounter. Ensure the operative note for each session specifies which lesion site is being treated so payers can distinguish the procedures and avoid a duplicate-claim denial.

Mira AI Scribe

Mira's AI scribe captures the number and anatomical locations of each lesion, the imaging modality and key radiologic findings (fluid-fluid levels, cortical expansion) per site, any biopsy or pathology results confirming ABC, and whether lesions are primary or secondary. This prevents downcoding to an unspecified or single-site code and supplies the audit-ready documentation needed when multi-site procedural claims are submitted.

See how Mira captures M85.59 documentation

Related ICD-10 codes

Ready?

Ready to transform your orthopedic practice?

See how orthopedic practices are running documentation, billing, and operations on a single voice-first platform.

Get started for free